NDC 0409-6476
Erythrocin Lactobionate
Erythromycin Lactobionate
Erythrocin Lactobionate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Erythromycin Lactobionate.
| Product ID | 0409-6476_70dedaf2-1fad-4b1a-b9a5-f116b50bdc7f |
| NDC | 0409-6476 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Erythrocin Lactobionate |
| Generic Name | Erythromycin Lactobionate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-03-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA062638 |
| Labeler Name | Hospira, Inc. |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Active Ingredient Strength | 500 mg/100mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |